Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndromes. ACCP evidenced-based clinical practice guidelines (2nd edition)

Chest

Volumn 132, Issue 3 SUPPL., 2007, Pages 149S-160S

  Spiro, Stephen G ^a   Gould, Michael K ^b   Colice, Gene L ^c  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Evaluation; Laboratory tests; Paraneoplastic syndrome; Signs; Symptoms

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; EVIDENCE BASED MEDICINE; HUMAN; LABORATORY TEST; LUNG CANCER; METASTASIS; PARANEOPLASTIC SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYMPTOMATOLOGY; LUNG TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY TRACT EXAMINATION;

DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; PARANEOPLASTIC SYNDROMES;

EID: 34848829857     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1358     Document Type: Article

References (89)

1. Scagliotti G. Symptoms, signs and staging of lung cancer. Eur Respir Mon 2001; 17:86-119
2. Andersen HA, Prakash UBS. Diagnosis of symptomatic lung cancer. Semin Respir Med 1982; 3:165-175
3. Grippi MA. Clinical aspects of lung cancer. Semin Roentgenol 1990; 25:12-24
4. Hyde L, Hyde CI. Clinical manifestations of lung cancer. Chest 1974; 65:299-306
5. Cromartie RS III, Parker EF, May JE, et al. Carcinoma of the lung. Ann Thorac Surg 1980; 30:30-35
6. Karsell PR, McDougall JC. Diagnostic tests for lung cancer. Mayo Clin Proc 1993; 68:288-296
7. American Thoracic Society, European Respiratory Society. Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 1997; 156:320-332
8. Buccheri G, Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur Respir J 2004; 24:898-904
9. Corner J, Hopkinson J, Fitzsimmons D, et al. Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis. Thorax 2005; 60:314-319
10. Hamilton W, Peters TJ, Round A, et al. What are the clinical features of lung cancer before the diagnosis is made? A population based case-controlled study. Thorax 2005; 60:1059-1065
11. Carbone PP, Frost JK, Feinstein AR, et al. Lung cancer: perspectives and prospects. Ann Intern Med 1970; 73:1003-1024
12. Koyi H, Hillerdal G, Branden E. A prospective study of a total material of lung cancer from a county in Sweden 1997-1999. Lung Cancer 2002; 36:9-14
13. Koyi H, Hillerdal G, Branden E. Patient's and doctors' delays in the diagnosis of chest tumors. Lung Cancer 2002; 35:53-57
14. Hamilton W, Sharp D. Diagnosis of lung cancer in primary care: a structured review. Fam Pract 2004; 21:605-611
15. Okkes IM, Oskam SK, Lamberts H. The probability of specific diagnoses for patients presenting with common symptoms to Dutch Family physicians. J Fam Pract 2002; 51:31-36
16. Quarterman RL, McMillan A, Rateliffe MB, et al. Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer. J Thorac Cardiovasc Surg 2003; 125:108-114
17. Aragoneses FG, Moreno N, Leon P, et al. Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer 2002; 36:59-63
18. Myrdal G, Lambe M, Hillerdal G, et al. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 2004; 59:45-49
19. British Thoracic Society. BTS recommendations to respiratory physicians for organising tire care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax 1998; 1:S1-S8
20. Reifel JL. Lung cancer. In: Asch SM, Kerr EA, Hamilton EG, et al, eds. Quality of care for oncologic conditions and HIV: a review of the literature and quality indicators. Santa Monica, CA: RAND Corporation, 2000
21. Garland LH. Bronchial carcinomas: lobar distribution of lesions in 250 cases. Calif Med 1961; 94:7
22. Macfarlane JCW, Doughty BJ, Crosbie WA. Carcinoma of the lung: an analysis of 362 cases diagnosed and treated in one year. Br J Dis Chest 1962; 56:57
23. Byers TE, Vena JE, Rzepka TF. Prediliction of lung cancer for the upper lobes: an epidemiologic inquiry. J Natl Cnacer Inst 1984; 72:1271
24. Quinn D, Gianlupi A, Broste S. The changing radiographic presentation of bronchogenic carcinoma with reference to cell types. Chest 1996; 110:1474
25. Byrd RB, Carr DT, Miller WE, et al. Radiographic abnormalities in carcinoma of the lung in relation to histological cell type. Thorax 1969; 24:573
26. Vincent RG, Pickren JW, Lane WW, et al. The changing histopathology of lung cancer. Cancer 1977; 39:1647-1655
27. Sider L. Radiographic manifestations of primary bronchogenic carcinoma. Radiol Clin North Am 1990; 28:583-597
28. Theros EG. 1976 Caldwell lecture: varying manifestation of peripheral pulmonary neoplasms. AJR Am J Roentgenol 1977; 128:893-914
29. Colice GL. Detecting lung cancer as a cause of hemoptysis in patients with a normal chest radiograph. Chest 1997; 111:877-884
30. Colice GL, Chapper GJ, Frenchman SM, et al. Comparison of computerized tomography with fiberoptic bronchoscopy in identifying endobronchial abnormalities in patients with known or suspected lung cancer. Am Rev Respir Dis 1985; 131:397-400
31. Yellin A, Rosen A, Reichert N, et al. Superior vena cava syndrome. Am Rev Respir Dis 1990; 141:1114-1118
32. Van Houtte P, De Jager R, Lustman-Marechal J, et al. Prognostic value of the superior vena cava syndrome as the presenting sign of small cell anaplastic carcinoma of the lung. Eur J Cancer 1980; 16:1447-1450
33. Ahmann FR. A reassessment of the clinical implications of the superior vena caval syndrome. J Clin Oncol 1984; 2:961-969
34. Mukai K, Shinkai T, Tominaga K, et al. The incidence of secondary tumors of the heart and pericardium. Jpn J Clin Oncol 1988; 18:19.5-201
35. Onuiigbo WIB. The spread of lung cancer to the heart, pericardium and great vessels. Jpn Heart J 1974; 15:234-238
36. Merchut MP. Brain metastases from undiagnosed systemic neoplasms. Arch Intern Med 1989; 149:1076-1080
37. Rohwedder JJ, Handley JA, Kerr D. Rapid diagnosis of lung cancer from palpable metastases by needle thrust. Chest 1990; 98:1393-1396
38. Feinstein AR. Symptomatic patterns, biologic behavior, and prognosis in cancer of the lung. Ann Intern Med 1964; 61:27-43
39. Feinstein AR. Symptoms as an index of biological behaviour and prognosis in human cancer. Nature 1966; 209:241-245
40. Feinstein AR. A new staging system for cancer and reappraisal of "early" treatment and "cure" by radical surgery. N Engl J Med 1968; 279:747-754
41. Feinstein AR, Wells CK. Lung cancer staging. Clin Chest Med 1982; 63:291-305
42. Feinstein AR, Wells CK. A clinical-severity staging system for patients with lung cancer. Medicine 1990; 69:1-33
43. Hooper RG, Beechler CR, Johnson MC. Radioisotope scanning in the initial staging of bronchogenic carcinoma. Am Rev Respir Dis 1978; 118:279-286
44. Hooper RG, Tenholder MF, Underwood GH, et al. Computed tomographic scanning of the brain in the initial staging of bronchogenic carcinoma. Chest 1984; 85:774-776
45. Silvestri GA, Lenz JE, Harper SN, et al. The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma. Chest 1992; 102:1748-1751
46. Quinn DL, Ostrow LB, Porter DK, et al. Staging of non-small cell bronchogenic carcinoma. Chest 1986; 89:270-275
47. Silvestri GA, Littenberg B, Colice GL. The clinical evaluation for detecting metastatic lung cancer. Am J Respir Crit Care Med 1995; 152:225-230
48. Spiro SG. Bronchial tumours. In; Brewis RAL, Corrin B, Geddes DM, eds. Respiratory medicine. London, UK: WB Saunders, 1995
49. Patel AM, Davila DG, Peters SG. Paraneoplastic syndromes associated with lung cancer. Mayo Clin Proc 1993; 68:278-287
50. Mazzone PJ, Arroliga AC. Endocrine paraneoplastic syndromes in lung cancer. Curr Opin Pulm Med 2003; 9:313-320
51. Bender RA, Hansen H. Hypercalcemia in bronchogenic carcinoma. Ann Intern Med 1974; 80:205-208
52. Bethune JE, Turpin RA. A study of urinary excretion of parathyroid hormone in man. J Clin invest 1968; 47:1583-1589
53. Kukreja SC, Shemerdiak WP, Lad TE, et al. Elevated nephrogenic cycle AMP with normal serum parathyroid hormone levels in patients with lung cancer. J Clin Endocrinol Metab 1980; 51:167-169
54. Riggs BL, Arnaud CD, Reynolds JC, et al. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest 1971; 50:2079-2083
55. Moseley JM, Kubota M, Diefenbach-Jagger H, et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A 1987; 84:5048-5052
56. Martin TJ, Moseley JM, Gillespie MT. Parathyroid hormone-related protein. Crit Rev Biochem Mol Biol 1991; 26:377-395
57. Hiraki A, Ueoka H, Bessho A, et al. Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia. Cancer 2002; 95:1706-1713
58. Maurer LH, O'Donnell JF, Kennedy S, et al. Human neurophysins in carcinoma of the lung. Cancer Treat Rep 1983; 67:971-976
59. Moses AM, Scheinman SJ. Ectopic secretion of neurohypophyseal peptides in patients with malignancy. Endocrinol Metab Clin North Am 1991; 20:489-506
60. Bliss DP Jr, Battey JF, Linnoila RI, et al. Expression of the atrial natriuretic factor gene in small cell lung cancer tumors and tumor cell lines. J Natl Cancer Inst 1990; 82:305-310
61. Padfield PL, Morton JJ, Brown JJ, et al. Plasma arginine vasopressin in the syndrome of antidiuretic hormone excess associated with bronchogenic carcinoma. Am J Med 1976; 61:825-831
62. Vorherr H. Para-endocrine tumor activity with emphasis on ectopic ADH secretion. Oncology 1974; 29:382-416
63. Johnson BE, Chute JP, Rushin J, et al. A prospective study of patients with lung cancer and hyponatremia of malignancy. Am J Respir Crit Care Med 1997; 156:1669-1678
64. List AF, Hainsworth JD, Davis BW, et al. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol 1986; 4:1191-1198
65. Mendelsohn G, Baylin SB. Ectopic hormone production: biological and clinical implications. Prog Clin Biol Res 1984; 142:291-316
66. Ilias K, Torpy D, Pacak K, et al. Cushing's syndrome due to ectopic corticotropin secretion. J Clin Endocrinol Metab 2005; 90:4955-4962
67. Odell WD, Wolfsen AR, Bachelot I, et al. Ectopic production of lipotropin by cancer. Am J Med 1979; 66:631-638
68. Hansen M, Bork E. Peptide hormones in patients with lung cancer. Recent Results Cancer Res 1985; 99:180-186
69. Myers KA, Farquhar DRE. Does this patient have clubbing? JAMA 2001; 286:341-347
70. Olan F, Portela M, Navarro C, et al. Circulating vascular endothelial growth factor concentrations in a case of pulmonary hypertrophic osteoarthropathy. J Rheumatol 2004; 31:614-616
71. Shneerson JM. Digital clubbing and hypertrophic osteoarthropathy. Br J Dis Chest 1981; 75:113-131
72. Sridhar KS, Lobo CF, Altman RD. Digital clubbing and lung cancer. Chest 1998; 114:1535-1537
73. Prakash U. Hypertrophic pulmonary osteoarthropathy and clubbing. In: Sackner MA, ed. Weekly updates: pulmonary medicine; lesson 30. Princeton, NJ: Biomedia, 1978; 2-7
74. Stenseth JH, Clagett OT, Woolner LB. Hypertrophic pulmonary osteoarthropathy. Dis Chest 1967; 52:62-68
75. Swash M, Schwartz MS. Paraneoplastic syndromes. In: Johnson RT, ed. Current therapy in neurologic disease. Philadelphia, PA: BC Decker, 1990; 236-243
76. Martina T, Clay AS. A 50-year-old woman with bilateral vocal cord paralysis and hilar mass. Chest 2005; 128:1028-1031
77. Mareska M, Gutmann L. Lambert-Eaton myasthenic syndrome. Semin Neurol 2004; 24:149-153
78. Ellington GM, Murray NMF, Spiro SG, et al. Neurological paraneoplastic syndromes in patients with small cell lung cancer: a prospective survey of 150 patients. J Neurol Neurosurg Psychiatry 1991; 54:764-767
79. Seute T, Leffers P, ten Velde GPM, et al. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 2004; 100:801-806
80. Lennon VA. Anti-Purkinje cell cytoplasmic and neuronal nuclear antibodies aid diagnosis of paraneoplastic autoimmune neurological disorders. J Neurol Neurosurg Psychiatry 1989; 52:1438-1439
81. Anderson NE, Rosenblum MK, Graus F, et al. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 1988; 38:1391-1398
82. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003; 349:1543-1554
83. Oguro-Okano M, Griesmann GE, Wieben ED, et al. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. Mayo Clin Proc 1992; 67:1150-1159
84. Pelucci A, Ciceri E, Clementi F, et al. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer. Am Rev Respir Dis 1993; 147:1229-1232
85. Dalmau J, Graus F, Rosenblum MK, et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuropathy. Medicine 1992; 71:59-72
86. Clamno GH, Evans WK, Shepherd FA, et al. Myasthenic syndrome and small cell cancer of the lung. Arch Intern Med 1984; 144:999-1000
87. Dropcho EJ. Autoimmune central nervous system paraneoplastic disorders. Ann Neurol 1995; 37:S102-S113
88. Croteau D, Owainati A, Dalmau J, et al. Response to cancer therapy in a patient with a paraneoplastic choreiform disorder. Neurology 2001; 57:719-722
89. Maddison P, Newsom-Davis J, Mills KR, et al. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell carcinoma. Lancet 1999; 353:117-118